Expression and clinical significance of PD-L1, B7-H3, B7-H4 and TILs in human small cell lung Cancer (SCLC)

Overview of attention for article published in Journal for Immunotherapy of Cancer, March 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (86th percentile)
Good Attention Score compared to outputs of the same age and source (78th percentile)

Mentioned by

twitter: 31 X users

Citations

dimensions_citation: 114 Dimensions

Readers on

mendeley: 118 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 35 X posts from 31 X users, with an upper bound of 309,606 followers.

RT @YaleIMed: New study: Supports evaluation of B7-H3 blockers &/or pro-inflammatory therapies in small cell lung cancer. Drs. Roy Herbst,…

01 May 2019

Reply Repost Favourite

RT @YaleIMed: New study: Supports evaluation of B7-H3 blockers &/or pro-inflammatory therapies in small cell lung cancer. Drs. Roy Herbst,…

30 Apr 2019

Reply Repost Favourite

New study: Supports evaluation of B7-H3 blockers &/or pro-inflammatory therapies in small cell lung cancer. Drs. Roy Herbst, Scott Gettinger, David Rimm, & Kurt Schalper et al published. https://t.co/jVrTF3X9Lz @YaleCancer @YaleMed @DrRoyHerbstYale

30 Apr 2019

Reply Repost Favourite

RT @sitcancer: #JITC Research: Expression and clinical significance of PD-L1, B7-H3, B7-H4 and TILs in human small cell lung Cancer (SCLC)…

01 Apr 2019

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 31 additional X posts.